Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. (2019)
Attributed to:
Cutaneous Immunology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aax2945
PubMed Identifier: 31645451
Publication URI: http://europepmc.org/abstract/MED/31645451
Type: Journal Article/Review
Volume: 11
Parent Publication: Science translational medicine
Issue: 515
ISSN: 1946-6234